ENvue Medical Inc.
ENvue Medical Inc. (FEED): 6 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
2.4 months
D/E 0.25 · 0% dilution
Lead: Approved
6 candidates
N/A
1 buy · 30 sells (180d)
A transparent, data-derived signal for ENvue Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$5.1M
Cash
$2.3M
Quarterly Burn
$4.3M
Runway
2.4 mo
Revenue
$653K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| envue system | Approved |
| painshield md | Approved |
| painshield plus | Approved |
| uroshield | Preclinical |
| uroshield ultra | Preclinical |
| woundshield | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
12
Total value held
$173K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 22,417 | $53K |
| schonfeld strategic advisors llc | 13,545 | $32K |
| morgan stanley | 10,000 | $24K |
| osaic holdings, inc. | 10,000 | $24K |
| international assets investment management, llc | 10,000 | $21K |
| poehling capital management, inc. | 10,000 | $17K |
| vanguard capital management llc | 378 | $900 |
| fmr llc | 324 | $771 |
| vanguard fiduciary trust co | 85 | $202 |
| wells fargo & company/mn | 45 | $107 |
Showing top 10 of 12 institutional holders of ENvue Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ENvue Medical Inc.'s pipeline?
ENvue Medical Inc. (FEED) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ENvue Medical Inc.'s lead drug candidate?
ENvue Medical Inc.'s most advanced tracked candidate is envue system (Approved) for Enteral feeding tube insertion.
What is ENvue Medical Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ENvue Medical Inc. has approximately 2.4 months of cash runway.
What is ENvue Medical Inc.'s market capitalization?
ENvue Medical Inc.'s market capitalization is approximately $5.1M.
Who is the CEO of ENvue Medical Inc.?
Dr. Doron Robert Besser M.D. is the chief executive officer of ENvue Medical Inc. (FEED).
Get the full picture on ENvue Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.